Market Overview:
The prenatal testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth of the market can be attributed to the increasing incidence of chromosomal abnormalities, rising demand for non-invasive tests, and technological advancements in prenatal testing. Based on type, the prenatal testing market is segmented into first-trimester screening tests, second-trimester screening tests, third-trimester screening tests, and diagnostic tests. The first-trimester screening test segment is expected to dominate the market during the forecast period owing to its high adoption rate due to its early detection ability for major chromosomal abnormalities such as Down syndrome. Based on application, the prenatal testing market is segmented into hospitals, pathology labs, gynecology clinics, and research organizations. The hospitals segment dominates the global prenatal testing market owing to rising number of pregnant women opting for hospital delivery across all regions covered in this study.
Product Definition:
Prenatal testing is a term used for medical procedures that are performed on a pregnant woman in order to assess the health of her fetus. This can include ultrasound, amniocentesis, and chorionic villus sampling.
First-Trimester Screening Tests:
The global First-Trimester Screening Tests, it's usage and growth factor in prenatal testing market size was valued at USD 1.1 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period.
Second-Trimester Screening Tests:
Second-trimester screening tests are used for the detection of genetic, congenital and other physical abnormalities in the fetus. These tests also aid in detecting any health risks to the fetus due to an imbalance in maternal health. The most common second trimester screening test includes a nonstress test (NST) and a fetal heart rate (FHR) monitor test along with an ultrasound imaging study of the baby’s anatomy.
Application Insights:
The research organizations segment dominated the global prenatal testing market in 2017. This can be attributed to increasing government funding for research related to pregnancy and childbirth. For instance, according to the U.S Department of Health & Human Services, National Institutes of Health (NIH), around USD 79 million was granted in 2016 for various projects related to pre-conception and conceptionrelated diseases in U.S alone.
Furthermore, prenatal testing is carried out at pathology laboratories as well as hospitals based on patient¢â‚¬â„¢s preference and availability of advanced diagnostic facilities at respective healthcare facilities. Hospitals dominate this segment due to their ability to provide better diagnosis owing to advanced equipment such as ultrasound machines and laboratory tests along with a larger panel of genetic analysis options compared with pathology laboratories across different regions globally., Diagnostic tests are expected register lucrative CAGR during the forecast period owingto its capability tounderstand complex disorders that affect multiple organ systems.
Regional Analysis:
North America dominated the global prenatal testing market in 2017. This can be attributed to the presence of well-established healthcare infrastructure, high adoption of advanced technologies, and availability of reimbursement facilities for genetic screening. Moreover, rising incidence of maternal disorders such as diabetes and obesity is expected to drive demand for diagnostic services related to maternal health over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to increasing government initiatives pertaining towards improving maternal care & health in emerging economies such as India and China.
Growth Factors:
- Increasing awareness about prenatal testing and its benefits among pregnant women and healthcare professionals.
- Rising incidence of genetic disorders and chromosomal abnormalities.
- Development of new, advanced prenatal tests that can detect a wider range of genetic disorders at an early stage.
- Growing demand for non-invasive prenatal tests (NIPT) due to their high accuracy and safety profile.
- Increasing number of pregnancies in the aging population
Scope Of The Report
Report Attributes
Report Details
Report Title
Prenatal Testing Market Research Report
By Type
First-Trimester Screening Tests, Second-Trimester Screening Tests, Third-Trimester Screening Tests, Diagnostic Tests
By Application
Hospitals, Pathology Labs, Gynecology Clinics, Research Organizations
By Companies
LabCorp, Sequenom, Quest Diagnostics, Illumina, Ariosa Diagnostics, Natera, Ravgen, Counsyl, Eurofins Ntd, Premaitha Health
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
123
Number of Tables & Figures
87
Customization Available
Yes, the report can be customized as per your need.
Global Prenatal Testing Market Report Segments:
The global Prenatal Testing market is segmented on the basis of:
Types
First-Trimester Screening Tests, Second-Trimester Screening Tests, Third-Trimester Screening Tests, Diagnostic Tests
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Pathology Labs, Gynecology Clinics, Research Organizations
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- LabCorp
- Sequenom
- Quest Diagnostics
- Illumina
- Ariosa Diagnostics
- Natera
- Ravgen
- Counsyl
- Eurofins Ntd
- Premaitha Health
Highlights of The Prenatal Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- First-Trimester Screening Tests
- Second-Trimester Screening Tests
- Third-Trimester Screening Tests
- Diagnostic Tests
- By Application:
- Hospitals
- Pathology Labs
- Gynecology Clinics
- Research Organizations
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Prenatal Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Prenatal testing is a procedure that can be used to determine the health of a fetus. This test can help identify any potential problems with the baby's development, including genetic disorders and birth defects.
Some of the major companies in the prenatal testing market are LabCorp, Sequenom, Quest Diagnostics, Illumina, Ariosa Diagnostics, Natera, Ravgen, Counsyl, Eurofins Ntd, Premaitha Health.
The prenatal testing market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Prenatal Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Prenatal Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Prenatal Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Prenatal Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Prenatal Testing Market Size & Forecast, 2020-2028
4.5.1 Prenatal Testing Market Size and Y-o-Y Growth
4.5.2 Prenatal Testing Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 First-Trimester Screening Tests
5.2.2 Second-Trimester Screening Tests
5.2.3 Third-Trimester Screening Tests
5.2.4 Diagnostic Tests
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Pathology Labs
6.2.3 Gynecology Clinics
6.2.4 Research Organizations
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Prenatal Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Prenatal Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 First-Trimester Screening Tests
9.6.2 Second-Trimester Screening Tests
9.6.3 Third-Trimester Screening Tests
9.6.4 Diagnostic Tests
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Pathology Labs
9.10.3 Gynecology Clinics
9.10.4 Research Organizations
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 First-Trimester Screening Tests
10.6.2 Second-Trimester Screening Tests
10.6.3 Third-Trimester Screening Tests
10.6.4 Diagnostic Tests
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Pathology Labs
10.10.3 Gynecology Clinics
10.10.4 Research Organizations
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 First-Trimester Screening Tests
11.6.2 Second-Trimester Screening Tests
11.6.3 Third-Trimester Screening Tests
11.6.4 Diagnostic Tests
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Pathology Labs
11.10.3 Gynecology Clinics
11.10.4 Research Organizations
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 First-Trimester Screening Tests
12.6.2 Second-Trimester Screening Tests
12.6.3 Third-Trimester Screening Tests
12.6.4 Diagnostic Tests
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Pathology Labs
12.10.3 Gynecology Clinics
12.10.4 Research Organizations
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 First-Trimester Screening Tests
13.6.2 Second-Trimester Screening Tests
13.6.3 Third-Trimester Screening Tests
13.6.4 Diagnostic Tests
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Pathology Labs
13.10.3 Gynecology Clinics
13.10.4 Research Organizations
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Prenatal Testing Market: Competitive Dashboard
14.2 Global Prenatal Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 LabCorp
14.3.2 Sequenom
14.3.3 Quest Diagnostics
14.3.4 Illumina
14.3.5 Ariosa Diagnostics
14.3.6 Natera
14.3.7 Ravgen
14.3.8 Counsyl
14.3.9 Eurofins Ntd
14.3.10 Premaitha Health
